Drug intelligence / Profile preview

GlucAffect

Development stage
Unknown
Lead developer
Reliv
Administration
Oral
01

Overview

GlucAffect is a proprietary **powder-based dietary supplement** developed by Reliv International, designed to support blood sugar management and promote weight loss, especially in individuals with metabolic syndrome or elevated blood glucose[2][4][6][10]. Its mechanism of action is primarily mediated by a blend of ingredients with known effects on glucose metabolism and antioxidant activity. Key active ingredients include LunaRich soy powder, Pycnogenol (a natural antioxidant), omega-3 fatty acids, Madeglucyl, Glucohelp, Silbinol, salacia extract, alpha-lipoic acid, and cinnamon. Pycnogenol is clinically shown to help lower high blood glucose levels and provide additional health benefits[2][14]. Clinical studies show that, combined with diet and exercise, GlucAffect supplementation significantly reduced fasting blood glucose and promoted substantial weight loss in overweight subjects with moderately elevated blood glucose[2][4][13]. The supplement is marketed and patented by Reliv International, with proprietary formulation and manufacturing processes[2][10][14]. GlucAffect is not classified as a pharmaceutical drug, but as a nutritional supplement.

Brand names
GlucAffect
Other names
GlucAffect
02

Targets

Sucrase-Isomaltase

Beyond the preview

Go deeper on GlucAffect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GlucAffect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call